Gilead Sciences in talks to expand global supply of COVID-19 drug remdesivir
Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.
Gilead Sciences last week received the U.S. Food and Drug Administration`s emergency use authorization for using remdesivir as a treatment against COVID-19. Photo: Reuters